Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 28, 2017
Reporting Period Referenced: Fiscal First Quarter ended August 31, 2017
This filing serves as a Regulation FD disclosure to furnish presentation slides regarding the company's fiscal first quarter performance. The information contained in the attached slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached presentation slides (Exhibit 99.1) rather than the body of the 8-K report.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It references the existence of presentation slides discussing the fiscal first quarter but does not summarize the specific variances or trends within the text of this report.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing presentation slides dated September 28, 2017, which discuss the fiscal first quarter results. The text of the 8-K does not include specific guidance, outlook statements, or risk factors; these are presumed to be in the attached exhibit.
Unusual Items: None disclosed in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated September 28, 2017) for actual financial figures and management commentary.
- Verify the specific revenue and earnings results for the fiscal quarter ended August 31, 2017, as they are not listed in the 8-K text.
- Confirm any forward-looking guidance or strategic updates provided in the attached slides.
- Note that the presentation slides are not incorporated by reference into other SEC filings.